Platinum Priority – EditorialReferring to the article published on pp. 186–193 of this issueClinical Management of Prostate Cancer in Men with BRCA Mutations
Referring to the article published on pp. 186–193 of this issue
Section snippets
Conflicts of interest
The authors have nothing to disclose.
References (10)
- et al.
Effect of BRCA mutations on metastatic relapse and cause-specific survival after radical treatment for localised prostate cancer
Eur Urol
(2015) - et al.
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
Eur Urol
(2014) - et al.
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation
Ann Int Med
(2014) - et al.
Clinical features and management of BRCA1 and BRCA2-associated prostate cancer
Front Biosci
(2014) - et al.
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer
J Clin Oncol
(2013)
There are more references available in the full text version of this article.
Cited by (10)
Familial prostate cancer
2016, Seminars in OncologyCitation Excerpt :Prostate cancer-specific survival has also been reported to be lower among screen-detected prostate cancer for individuals carrying a BRCA2 mutation compared to non-carriers (61.8% v 94.3%, P <10-4) [30]. Another study reported no significant difference in response of castrate-resistant prostate cancer to taxane-based therapy between BRCA mutation carriers versus non-carriers in an Ashkenazi Jewish population [87], providing further insight into potential systemic treatment for prostate cancer patients carrying BRCA mutations. While genetically-based treatment guidelines do not currently exist for prostate cancer, expert opinion is emerging regarding how to consider individualizing management [88].
Analysis of BRCA Germline Mutations in Chinese Prostate Cancer Patients
2022, Frontiers in OncologyGenetics of prostate cancer
2019, Journal fur Urologie und UrogynakologieFrequency of variants in dna-repair genes in a southwest colombian population
2019, Urologia ColombianaMen’s and Women’s Approaches to Disclosure About BRCA-Related Cancer Risks and Family Planning Decision-Making
2018, Qualitative Health Research
Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.